Trial design, setting, participants, and interventions
BLIND
Prospective randomised, parallel arms, placebo-controlled, double blind, clinical trial at Karolinska University Hospital, Sweden.We plan to enroll 80 previously healthy subjects diagnosed with PCC (U09.9) randomised (1:1) to HBOTrial flowchart of the HOT-LoCO trialCONSORT Flow diagram of the Safety analysis